Dr. Abbey Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the
read moreDr. Abbey Presents at the American Society of Retina Specialists 2022 Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, is presenting this week at the 40th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) in New York City. ASRS is the
read moreSeven Texas Retina Associates Physicians Earn New Professional Designation
The American Society of Retina Specialists has awarded its Fellow of the ASRS (FASRS) designation to the following Texas Retina Associates physicians: David Callanan, MD Rajiv Anand, MD Michel J. Shami, MD
read moreDr. Kothari Actively Involved in Women in Retina Mentoring Program
Texas Retina Associates’ Dr. Nikisha Kothari is actively involved in the Women in Retina (WinR) Mentoring Program, a part of the American Society of Retina Specialists (ASRS). Tonight she is serving on
read moreDr. Kothari’s Research on Microincisional Vitrectomy Surgery Published in International Medical Journal
Texas Retina Associates’ Nikisha Kothari, MD, recently had a research study published in the Journal of VitreoRetinal Diseases, the peer-reviewed journal of the American Society of Retina Specialists (ASRS). Titled “A Multicenter
read moreNew AAO Video Highlights Dr. Anand Discussing Recent Clinical Trial on Ranibizumab for Patients Who Develop Radiation Retinopathy After Treatment for Uveal Melanoma
An interview with Texas Retina Associates’ Rajiv Anand, MD, is featured by the American Academy of Ophthalmology (AAO) in their latest video from the recent 2018 American Society of Retina Specialists (ASRS) annual
read more